ASP Isotopes Inc. Common Stock (ASPI) Stock Analysis & Investment Frameworks
ASP Isotopes Inc. Common Stock (ASPI) stock analysis on Invetso. Review ASP Isotopes Inc. Common Stock’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
ASP Isotopes Inc. Common Stock Company Overview
- Exchange: NASDAQ Global Market
- Sector: Basic Materials
- Industry: Chemicals - Specialty
- Country: US
ASP Isotopes Inc. Common Stock Key Financial Metrics
- Market Cap: $324.71M
- Revenue: $23.85M
- ROE: -63.49%
- ROIC: -17.29%
- Dividend Yield: N/A
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
ASP Isotopes Inc. Common Stock Investment Frameworks
Invetso analyzes ASP Isotopes Inc. Common Stock (ASPI) across the following frameworks:
- ASP Isotopes Inc. Common Stock 10Y Growth Potential
- ASP Isotopes Inc. Common Stock Scenario Analysis
- ASP Isotopes Inc. Common Stock Risks & Opportunities
- ASP Isotopes Inc. Common Stock Economic Moat
- ASP Isotopes Inc. Common Stock Business Model
- ASP Isotopes Inc. Common Stock Management
- ASP Isotopes Inc. Common Stock SWOT Analysis
- ASP Isotopes Inc. Common Stock Porter's 5 Forces
- ASP Isotopes Inc. Common Stock PESTLE Analysis
- ASP Isotopes Inc. Common Stock ESG Analysis